Resources

4 Resources for

jack haddad, md, mba, cmt

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Resources

Amylin's Pullback Is Unjustified
In a 6-6 vote by the FDA Scientific Advisory Committe, it was determined that Liraglutide (a diabetes drug made by Novo Nordisk NVO) posed a significant risk in causing thyroid tumors in humans. While the panel was worried about animal studies showing that liraglutide caused medullary thryroid cancer...
Tags: Biotech, Healthcare, Jack Haddad, MD, MBA, CMT, Amylin Pharmaceuticals Inc., NUVO Network Management Inc.
External links 2009-04-09
Intel: Both Technically and Fundamentally Compelling
All in all, Intel [[INTC]] has had a very busy year. The company has launched more than 13 new chips since the start of the year and has been investing heavily to speed up the design of new microprocessors in order to combat rival [[AMD]]. Definitely, their plan to...
Tags: Chip, Jack Haddad, MD, MBA, CMT, Intel Corp.
External links 2009-04-17
Seagate Turnaround Plan Is Already Succeeding
Seagate STX CEO Steve Luco's 2 million turnaround plan is already bearing fruit. Higher volume sales and cost controls has helped the disk drive maker earn at least 7% gross margins for the quarter, better than earlier estimates, according to the company's management. Cash increased $200 million to...
Tags: Hardware, Jack Haddad, MD, MBA, CMT, Seagate Technology LLC
External links 2009-04-20
PetSmart: Cause for Optimism
Shares of the company sold significantly Friday. However, according to estimates by the American Pet Products Association, spending on pets will remain strong despite our current recession. The agency estimates that in 2009 close to $45 billion on pets will be spent; this figure is a 5.1% increase...
Tags: Retail, Jack Haddad, MD, MBA, CMT, Petsmart
External links 2009-05-24
  • << Previous
  • page 1 of 1
  • Next >>
advertisement
advertisement
Click Here